Cancer drugs

Cancer drugs

Drugs, agents used in the treatment of cancer or conditions related to cancer.

Industry: Pharmaceutical

Add a new term

Contributors in Cancer drugs

Become a Contributors

Cancer drugs

PI3K delta inhibitor CAL-101

Pharmaceutical; Cancer drugs

A small molecule inhibitor of the delta isoform of the 110 kDa catalytic subunit of class IA phosphoinositide-3 kinases (PI3K) with potential immunomodulating and antineoplastic activities. ...

ramucirumab

Pharmaceutical; Cancer drugs

A recombinant, fully human monoclonal antibody directed against human vascular endothelial growth factor receptor 2 (VEGFR-2) with antiangiogenesis activity. Ramucirumab specifically binds to and ...

anamorelin hydrochloride

Pharmaceutical; Cancer drugs

The orally bioavailable hydrochloride salt of a synthetic, small-molecule ghrelin mimetic with appetite-stimulating and anabolic activities. Anamorelin binds to and stimulates the growth hormone ...

An orally bioavailable, highly soluble phosphate prodrug of B-raf (BRAF) protein kinase with potential antineoplastic activity. BRAF inhibitor ARQ 736 is converted into its active form ARQ 680 in the ...

Lutetium Lu 177-DOTA-octreotate

Pharmaceutical; Cancer drugs

A radioconjugate consisting of the somatostatin analogue octreotate labelled with lutetium Lu 177 with receptor ligand, beta-emitting radioisotope, and potential antineoplastic activities. Lutetium ...

(18F)-labeled substance P antagonist receptor quantifier

Pharmaceutical; Cancer drugs

A radioconjugate consisting of the positron emitting radioisotope fluorine F 18 conjugated to the substance P antagonist receptor quantifier (SPA-RQ) used in radioimaging. (18F)-labeled substance P ...

Lutetium Lu 177-DOTA-edotreotide

Pharmaceutical; Cancer drugs

A radioconjugate consisting of the octreotide derivative edotreotide (Tyr3-octreotide or TOC) labelled with lutetium Lu 177 with receptor ligand, beta-emitting radioisotope, and potential ...